(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Crispr Therapeutics is 964177
| Date | Daily Closing Price | Open | High | Low | Volume |
| 30 Tue Dec 2025 | 53.19 | 54.06 | 54.12 | 52.98 | 1.414 times |
| 29 Mon Dec 2025 | 53.97 | 55.05 | 55.41 | 53.80 | 0.765 times |
| 26 Fri Dec 2025 | 55.06 | 56.77 | 56.77 | 53.76 | 0.9 times |
| 24 Wed Dec 2025 | 56.71 | 56.45 | 56.83 | 55.21 | 0.677 times |
| 23 Tue Dec 2025 | 56.46 | 57.10 | 57.24 | 55.81 | 1.392 times |
| 22 Mon Dec 2025 | 57.90 | 56.50 | 59.18 | 54.50 | 1.236 times |
| 19 Fri Dec 2025 | 55.84 | 55.16 | 58.00 | 55.00 | 0.843 times |
| 18 Thu Dec 2025 | 54.84 | 55.27 | 57.03 | 54.70 | 0.765 times |
| 17 Wed Dec 2025 | 54.74 | 55.66 | 58.00 | 54.60 | 0.612 times |
| 16 Tue Dec 2025 | 55.97 | 55.68 | 57.58 | 55.29 | 1.187 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 54.3, but if it comes above 54.3, then a intra day buy could be more profitable.
If you take a sell trade below 54.3, then use 54.3 as stoploss and 52.3 as target. However if you take a buy trade in stock , then use 54.3 as stoploss and 56.01 as target.
Share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Target | 48.02 |
| Downside Target | 50.83 |
| Downside Target | 52.98 |
| Upside Target | 58.35 |
| Upside Target | 59.25 |
| Upside Target | 59.77 |
| Upside Target | 60.53 |
| Upside Target | 60.64 |
| Upside Target | 61.44 |
| Upside Target | 66.29 |
| Upside Target | 78.48 |
Intraday share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Intraday Target | 52.31 |
| Downside Intraday Target | 51.43 |
| Upside Intraday Target | 54.74 |
| Upside Intraday Target | 56.29 |
| Upside Intraday Target | 53.86 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 30 Tue Dec 2025 | 53.19 | 55.05 | 55.41 | 52.98 | 0.518 times |
| 26 Fri Dec 2025 | 55.06 | 56.50 | 59.18 | 53.76 | 0.836 times |
| 19 Fri Dec 2025 | 55.84 | 57.12 | 58.35 | 54.60 | 0.622 times |
| 12 Fri Dec 2025 | 56.68 | 58.12 | 59.25 | 54.41 | 0.976 times |
| 05 Fri Dec 2025 | 56.87 | 52.30 | 59.77 | 51.00 | 1.47 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 30 Tue Dec 2025 | 53.19 | 52.30 | 59.77 | 51.00 | 0.679 times |
| 28 Fri Nov 2025 | 53.47 | 59.97 | 60.64 | 48.02 | 0.696 times |
| 31 Fri Oct 2025 | 63.99 | 64.75 | 78.48 | 60.53 | 1.141 times |
| 30 Tue Sep 2025 | 64.81 | 50.99 | 66.29 | 50.83 | 0.961 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 55.52 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 55.52 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

